If you've decided to bank your baby's cord blood privately, the next decision is bigger than most parents expect: how to choose a cord blood bank in the US. The good news is that cord blood banking is one of the few healthcare services where the right evaluation criteria are concrete, comparable, and accessible to any parent willing to spend an hour on the homework. This guide gives you a 10-point checklist for choosing the right bank — the same questions you'd want a friend in the industry to ask on your behalf.
The goal is to leave you with a structured way to compare banks side-by-side, the confidence to spot marketing fluff, and a clear sense of what actually matters when your baby's cells will be stored for the next 20 to 30 years.
Why the choice matters more than the marketing suggests
The biology of cord blood is identical regardless of which bank stores it. What varies — significantly — is everything around the biology: how the unit is collected, processed, transported, accredited, and stored; how long the company has been in business; how reliable the storage facility is; what financial protections back the service; and how the bank coordinates release if your family ever needs the cells clinically.
Those variables determine whether the banked unit will actually be usable when it matters. They also determine whether you're paying a fair price for what you're getting.
The 10-point checklist below is designed to make that comparison fast and honest.
The 10-point checklist for choosing a cord blood bank
1. AABB accreditation. AABB (formerly the American Association of Blood Banks) accreditation is the gold standard for cord blood storage in the US. AABB-accredited facilities undergo rigorous inspection, validated processing standards, and ongoing quality oversight. Not every private bank in the US is AABB-accredited.
2. FDA registration. Cord blood banks operating in the US must register with the FDA, which regulate human cells, tissues, and cellular and tissue-based products. Verify that the bank is FDA-registered. This is a baseline regulatory requirement — not a quality differentiator — but it's a non-negotiable starting point.
3. AATB accreditation (for tissue products). If you're considering banking cord tissue or placental tissue in addition to cord blood, look for AATB (American Association of Tissue Banks) accreditation. AATB sets the standards for tissue product storage in the US, and it's particularly relevant for banks offering bundled cord blood + cord tissue + placenta packages.
4. Years in continuous operation. Cord blood banking is a multi-decade service. The bank you choose at birth should still exist when your child is 25. Ask how long the bank has been in continuous operation, whether it's been acquired or restructured, and whether the facility holding your cells has changed hands. Banks with 15+ years of continuous operation are more likely to be around when your family actually needs the cells.
5. Processing method. How a bank processes cord blood directly affects the yield of viable stem cells stored. The total nucleated cell (TNC) count at processing is one of the strongest predictors of engraftment success in transplant medicine. Ask the bank specifically about processing methodology and stem cell recovery rate.
6. Storage architecture. Most cord blood units are stored as a single sample, which means one use empties the unit. Some banks (including AlphaCord) use multi-chamber storage bags that divide a single collection into multiple separately accessible aliquots — supporting up to five potential treatments from one banking decision. For families thinking about cord blood as a long-term resource, multi-chamber storage extends the value of one collection meaningfully.
7. Pricing structure and transparency. Cord blood banking pricing is typically structured as an upfront enrollment fee plus annual storage. Ask for the full cost over 20 years (upfront + storage × years), and verify that there are no hidden fees for sample release, transport, or coordination with a future fertility or transplant clinic.
8. Engraftment guarantee or quality guarantee. Some US private banks offer financial guarantees in the rare case that stored cells fail to engraft when used clinically. Look for guarantees that specify a clear dollar amount, the conditions under which the guarantee applies, and the documented process for invoking it. AlphaCord's engraftment guarantee, for example, pays families up to $85,000 if banked cord blood fails to engraft in an approved transplant.
9. Sample release process. Cord blood is only useful if the bank can release it to a treatment facility when needed. Ask the bank what its sample release process looks like — how long does release take, what documentation is required, which transplant centers and fertility clinics they've worked with previously, and whether they coordinate transport. A bank with documented experience releasing samples for clinical use is preferable to one that has theoretical capability.
10. Customer support and continuity. Cord blood banking is a relationship measured in decades. Ask about how the bank communicates with families over time, what happens if the company is acquired or restructured, and how the bank handles billing changes, family contact updates, or directives for sample use. Long-term, low-touch customer infrastructure is more important than the sales call experience.
These ten items, evaluated side-by-side across two or three candidate banks, will produce a clearer picture than any volume of marketing copy.
The science behind the checklist
Several of the items on the checklist tie directly to peer-reviewed evidence on cord blood transplant success — which is why they matter, not just as quality signals but as predictors of clinical usefulness.
A 2010 study in Stem cell Translational Medicine found that the total nucleated cell (TNC) dose at collection is one of the strongest predictors of cord blood transplant success — directly linking processing methodology and recovery rate to real clinical outcomes. The implication is that banks with higher-quality processing don't just produce nicer paperwork; they produce cord blood units more likely to work when used.
A 2022 study in Therapeutic Advances in Hematology established that adult patients receiving double cord blood transplants for acute leukemia had comparable survival outcomes to those receiving matched unrelated donor transplants — establishing cord blood as a fully validated treatment option and underscoring why long-term storage reliability matters. A unit that's not viable when needed is no better than no unit at all.
A 2025 review in Blood Cell Therapy reported successful neutrophil engraftment in over 80% of well-matched cord blood transplants, with engraftment rates significantly correlated with TNC dose. Again, the takeaway: the quality of collection and processing isn't a marketing claim. It's a predictor of clinical outcome.
The checklist items aren't arbitrary criteria — they're proxies for the variables that the published transplant literature has shown matter most.
How AlphaCord stacks up against the 10-point checklist
AlphaCord was founded in 2002 by parents who believed cord blood banking shouldn't be a luxury reserved for high earners. The company's offering is built specifically to score well against the 10-point checklist above — quality and affordability designed to coexist.
- AABB and AATB accredited. AlphaCord samples are stored at the CryoPoint Biorepository in Brownsburg, Indiana — AABB-accredited, AATB-accredited, and FDA-registered. The full accreditation profile covers cord blood, cord tissue, and placental tissue.
- 24+ years in continuous operation. AlphaCord has been operating continuously since 2002, with more than two decades of customer infrastructure, processing experience, and clinical release coordination behind the business. The company is part of the CSG.BIO Group, with more than 750,000 samples in storage globally.
- 3-in-1 collection kit. A single collection captures cord blood, cord tissue, and placental tissue from one delivery. The kit is temperature-protected and electronically tracked from hospital to lab, which directly protects cell viability during transit.
- 5-chamber storage bag. AlphaCord's storage architecture divides a cord blood unit into up to five separately accessible aliquots, supporting multiple potential treatments from one banking decision.
- Transparent, affordable pricing from $81/month. AlphaCord plans are designed to keep banking accessible without compromising on accreditation or quality. The pricing is published transparently, with options to bundle cord blood, cord tissue, and placenta. Browse AlphaCord banking plans.
- Engraftment guarantee up to $85,000. Among the strongest financial protections in the US private banking market. If banked cord blood fails to engraft in an approved transplant, AlphaCord reimburses the family up to $85,000.
- Sample release coordination. AlphaCord coordinates sample release to transplant centers and fertility clinics anywhere in the world, with established processes for documentation and transport.
The result is a banking option built specifically to score well across every item on a serious evaluation checklist — and to do so at a price point that works for everyday American families.
Frequently Asked Questions
What's the single most important factor when choosing a cord blood bank? AABB accreditation. It's the most reliable single quality signal in the US private banking market and a non-negotiable starting point. Banks that aren't AABB-accredited may be operating legally (with FDA registration alone) but lack the rigorous, validated processing standards that AABB requires.
Are bigger cord blood banks always better than smaller ones? Not necessarily. What matters is accreditation, processing quality, years of continuous operation, and the storage facility itself — not company size. Some larger banks have premium pricing that doesn't reflect proportional quality differences. Some smaller, focused banks offer excellent service at lower cost.
What happens if my cord blood bank goes out of business? This is a legitimate concern and an important question to ask any bank. Reputable US private banks have continuity plans that transfer samples to another accredited facility in the case of business changes. Ask about ownership history, parent company structure, and continuity protocols before enrolling.
Should I bank cord blood only, or also cord tissue and placenta? Cord blood contains hematopoietic stem cells (used in current transplant medicine for 80+ conditions). Cord tissue contains mesenchymal stem cells (MSCs) with emerging applications in regenerative medicine. Placental tissue is another rich source of MSCs and other cell populations. Bundled banking captures all three from a single delivery and broadens future treatment optionality.
Choose carefully, once
Cord blood banking is a decision your family makes once and lives with for decades. The right bank isn't the one with the loudest marketing — it's the one that scores well on every item that actually matters. Run any candidate bank through the 10-point checklist above before you sign, and you'll make a decision you can stand behind for the next 20 years.
